For decades, experts recommended the lowest dose of hormone replacement therapy (HRT) for the shortest possible time. However, recent updates from the FDA and The Menopause Society changed the conversation to a more nuanced and individualized approach. 

When evaluating HRT and postmenopause ongoing use, you must view safety as an ongoing, personalized assessment. Read on to learn how your unique health history, medication timing, and symptoms can help you make an informed decision about your long-term care.

How have clinical recommendations about HRT duration changed?

The long-standing “minimum dose for the shortest time” rule largely stems from the Women’s Health Initiative (WHI), a major study published in 2002. The WHI examined hormone therapy’s long-term risks and benefits in postmenopausal women.

Researchers ended the study early after reporting increased health risks. These risks included higher rates of breast cancer, coronary heart disease (CHD), stroke, and blood clots in the lungs (pulmonary embolism). As a result, the medical community adopted the “shortest duration” guidance as a precaution. However, the advice responded to the trial’s overall findings rather than direct evidence that risk rose over time.

Several nuances complicate a straightforward reading of those 2002 findings today:

• Age: On average, study participants started HRT years after the age at which most women today begin treatment.
• Formulation: The trial tested a single, fixed-dose oral estrogen-progestin combination that’s no longer commonly prescribed. 

Interpreting the data also requires distinguishing between relative and absolute risk. Relative risk compares the rate of an event between two groups, like people on HRT versus people on placebo. Absolute risk shows the actual probability of the event happening to a single person, providing a more accurate sense of the true impact. 

The study’s relative risk increases sound alarming; for example, women had a 113% higher relative risk of pulmonary embolism. But in absolute terms, that meant about eight additional cases each year for every 10,000 women. That’s approximately a 0.08% increase in absolute risk. 

Because of these complexities, clinical standards evolved. In its 2022 Hormone Therapy Position Statement, The Menopause Society concluded that no single age or time limit fits everyone for discontinuation. Clinicians now take a more personalized stance. In early 2026, the FDA moved in the same direction by removing the “lowest effective dose for the shortest duration” language from HRT labels. 

What are the benefits of continuing HRT after menopause?

Menopause involves three distinct stages: perimenopause, menopause, and postmenopause. During these phases, hormones like estrogen and progesterone fluctuate unpredictably before settling at a lower baseline. These changes cause vasomotor symptoms (VMS), sleep disturbances, and vaginal dryness. HRT supplements these hormones, restoring hormonal balance and managing common symptoms.

For example, up to 80% of postmenopausal women experience VMS like hot flashes and night sweats. A systematic review published in the Cochrane Database of Systematic Reviews (CDSR) found that HRT reduced the frequency and severity of hot flashes by approximately 75% compared with placebo.

Over time, menopause symptoms will lessen as the body adjusts to the new, lower hormonal baseline. But that doesn’t necessarily mean you need to stop using HRT, as it may support broader long-term health outcomes in the following ways. 

Cardiovascular health 

Women who begin HRT before age 60 or within 10 years of menopause’s onset (the “window of opportunity”) often experience favorable outcomes in their cardiovascular health. One randomized trial found that those on HRT for 10 years had a significantly lower risk of serious cardiovascular events including heart attack and heart failure.

But timing shapes cardiovascular health benefits. Starting later may not carry the same benefits and could even increase risk in some individuals. For instance, research in Frontiers in Reproductive Health notes that women starting HRT at age 70 (or 20 years after menopause’s onset) face increased coronary risk. 

Metabolic health

Menopause often drives metabolic shifts like increased abdominal fat, disrupted sleep, and frequent fatigue. By restoring the hormonal environment, HRT helps address these symptoms and supports better metabolic health. Specifically, HRT targets insulin resistance, a primary driver of poor metabolic health. A systematic review published in Climacteric confirmed that HRT meaningfully reduces insulin resistance in healthy postmenopausal women. 

Genitourinary health 

Over 40% of postmenopausal women experience genitourinary syndrome of menopause (GSM). This condition includes:

• Vaginal dryness and irritation
• Pelvic pain
• Pain during sex (dyspareunia) 
• Decreased libido
• Painful urination and urinary urgency

GSM is often progressive; it rarely improves on its own and usually worsens without treatment. Because of this, many women continue HRT to manage symptoms. Standardized clinical guidelines from The American Urological Association highlight HRT as an effective intervention for GSM when prescribed appropriately. 

What are the risks of long-term HRT use?

Long-term HRT use carries potential risks. For example, combined estrogen-progestin therapy is linked to increased breast cancer risk. And estrogen-only therapy may increase the risk of endometrial cancer for women who still have a uterus.

Multiple factors, like your specific hormone formulation, the timing of initiation, and your overall treatment length, usually influence your risk profile. This applies to to other potential concerns, too, like: 

• Ovarian or endometrial cancer
• Dementia
• Stroke
• Gallbladder disease

These potential risks don’t mean HRT is unsafe for you. Instead, they highlight the importance of ongoing monitoring. Your doctor will weigh these factors against your personal health history to help you build a care plan that balances long-term safety with quality of life.

What happens when you stop HRT?

The right time to stop HRT varies from person to person. When you and your doctor decide to discontinue therapy, your provider will likely guide you through a gradual dose reduction. While research comparing gradual tapering to stopping abruptly remains limited, most clinicians recommend tapering to minimize negative side effects.

Discontinuation can involve risk as your body adjusts to lower hormone levels. About 50% of cases experience a return of VMS or GSM. This makes ongoing health monitoring essential throughout the process to support your body as your needs evolve. 

Maven Clinic: There with you every step 

Your health needs will change as you transition through postmenopause. Because your hormonal baseline, symptom profile, and risk factors evolve over time, your care plan needs to as well. 

At Maven Clinic, we build care plans to adapt to these changes. Whether you’re beginning HRT for symptom relief or reassessing your long-term needs, our team of specialists across more than 30 disciplines helps you navigate your next right step. 

That’s why millions of women trust Maven Clinic to support them through the most demanding stages of their lives, including postmenopause. 

Discover our approach to hormone care. 

FAQ

How long can you be on HRT safely?

There’s no set limit. Because everyone’s needs and risk profiles differ, your care time will proactively monitor your progress to ensure HRT remains the right choice for you over time.

What are the signs that you need hormone replacement therapy?

If you experience persistent perimenopause symptoms that affect your quality of life, discuss HRT with your doctor. Common symptoms include: 

• Menstrual cycle irregularity
• Hot flashes and night sweats
• Sleep disturbances 
• Mood instability 
• Vaginal dryness
• Brain fog 

Can you start HRT after menopause?

Yes. If you’re postmenopausal, you may fall outside of the “window of opportunity” (within 10 years of menopause’s onset or before age 60). But that doesn’t automatically disqualify you from starting HRT. Your care team will carefully weigh the risks and benefits based on your specific health profile.

What’s estrogen?

Estrogen is a group of sex hormones that our bodies naturally produce. It plays critical roles across a range of bodily functions, from genitourinary to cardiovascular health. HRT supplements declining estrogen levels during menopause to restore hormonal balance and manage physical symptoms.

‍